Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : VLP-N-00034
| Cat. No. | VLP-N-00034 |
| Description | Virus-Like Particles that contain structurally intact Human SMO protein, designed for antibody screening and ligand binding assays etc. |
| Gene Abbr | SMO |
| Gene Name | SMO smoothened, frizzled family receptor [ Homo sapiens ] |
| Applications | Human Smoothened (SMO) virus-like particles (VLPs) are engineered virus-like structures that display the SMO protein, which is a component of the Hedgehog signaling pathway. This pathway is critical in embryonic development and has been implicated in several types of cancer and other diseases. The applications of human SMO VLPs are varied and include: Vaccine development: VLPs are often used in vaccine formulations because they can mimic the structure of actual viruses without being infectious. SMO VLPs could potentially be used to develop vaccines that elicit an immune response against the SMO protein, providing a new approach to treating cancer or other diseases associated with aberrant SMO activity. Drug screening and development: Researchers can use SMO VLPs to screen for new drugs that target the SMO protein. These particles can provide a safe and effective platform for high-throughput screening of compounds that modulate Hedgehog signaling. Basic research: SMO VLPs can be used as a tool for basic research to better understand the role of the SMO protein in the Hedgehog signaling pathway. Understanding the structure-function relationship of this protein can provide insights into its role in normal and disease states. Diagnostics: SMO VLPs can be used to develop diagnostic tools. For example, they could help develop assays to detect the presence of SMO proteins in various tissues or quantify their activity, which could help diagnose certain cancers or developmental disorders. Immunotherapy: Given the importance of SMO proteins in cancer, SMO VLPs could be explored as a basis for developing immunotherapies. These particles could potentially help train the immune system to recognize and attack cells that express abnormally high levels of SMO proteins. |
| Storage | -80˚C |
| Shipping | Dry ice |
| Gene Name | SMO smoothened, frizzled family receptor [ Homo sapiens ] |
| Gene Symbol | SMO |
| Synonyms | Gx; SMOH; FZD11 |
| Gene ID | 6608 |
| Uni Prot ID | A4D1K5 |
| m RNA Refseq | NM_005631.4 |
| Protein Refseq | NP_005622.1 |
| Chromosome Location | 7q32.3 |
| Function | G-protein coupled receptor activity; PDZ domain binding; Wnt-activated receptor activity; Wnt-protein binding; drug binding; patched binding; protein binding; |
| Pathway | Basal cell carcinoma, organism-specific biosystem; Basal cell carcinoma, conserved biosystem; Class B/2 (Secretin family receptors), organism-specific biosystem; GPCR ligand binding, organism-specific biosystem; GPCRs, Other, organism-specific biosystem; Hedgehog Signaling Pathway, organism-specific biosystem; Hedgehog signaling events mediated by Gli proteins, organism-specific biosystem; |
| MIM | 601500 |
The SMO gene, or smoothened frizzled receptor, is a key component in the Hedgehog (Hh) signaling pathway and plays an important role in embryonic development, tissue patterning, and stem cell regulation. The SMO gene is located on human chromosome 7q32.1 and encodes a G protein-coupled receptor (GPCR). The receptor is an integral part of Hedgehog pathway signaling, which is essential for the normal development and organization of various tissues and organs. Aberrant SMO activity has been implicated in a variety of cancers, including basal cell carcinoma and medulloblastoma. Therefore, SMO is not only a key player in developmental biology, but also a potential target for therapeutic intervention in cancer treatment.
Because understanding and exploring the function of the SMO protein is critical for both basic biological research and therapeutic intervention, innovative tools have been developed to facilitate more efficient research, such as human SMO virus-like particles (VLPs). VLPs are molecular mimics of actual viruses, but lack viral genetic material, so they are non-infectious and safe to use in a variety of experimental settings. Their highly repetitive structure allows for the presentation of overexpressed target proteins, such as SMO, in a native conformation, thereby retaining their biological activity. By incorporating a structurally intact human SMO protein into VLPs, researchers can generate highly relevant models of SMO-related signaling processes without the complexity that comes with a full-live viral system.
A: Yes.Human SMO Virus-Like Particles are derived from viruses but retain none of their infection or replication capabilities. These protein particles have defined surface chemistries, uniform sizes, and stability properties that make them attractive starting points for drug-delivery scaffolds.
A: Human SMO Virus-Like Particles are formed by the self-assembly of viral envelope/coat proteins. The membrane proteins are composed in situ from VLPs produced from HEK293 cell cultures. These VLPs concentrate conformationally intact membrane proteins directly on the cell surface and produce soluble, highly concentrated proteins that are well suited for immunization and antibody screening.
A: Human SMO Virus-Like Particles (VLPs) are protein assemblies that mimic the structure of the human SMO receptor, facilitating research of SMO-related diseases, such as cancer. These VLPs are produced by recombinant expression in mammalian cells and then purified using chromatography techniques.
A: Human SMO Virus-Like Particles play a crucial role in studying the interaction between SMO receptors and potential therapeutic drugs. They can be used as a tool for functional and structural analyses of SMO, screening and development of small molecule drugs, and evaluation of drug candidate efficacy in cell-based assays or animal models.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The product is expressed by mammalian cells, which is closer to the real conformation and has good activity.
Human SMO virus-like particles have been very useful in my antibody screening and have helped me to screen for good antibodies.
The quality and purity of this product is exceptional, and they have consistently provided reproducible results in our experiments. I highly recommend Human SMO Virus-Like Particles products to any researcher working in the field of SMO signaling and drug discovery.
As a pharmaceutical company, we have been using Human SMO Virus-Like Particles products for our drug development projects, and we couldn't be happier with the outcome. These virus-like particles have allowed us to effectively assess the binding abilities of potential drug candidates to the SMO receptor, providing valuable insights into their pharmacological activities.
I am extremely satisfied with Human SMO Virus-Like Particles products and will continue to use them in my studies.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.